Two-Layered Dissolving Microneedles for Percutaneous Delivery of Peptide/Protein Drugs in Rats
暂无分享,去创建一个
Keizo Fukushima | Kanji Takada | Hiromi Morita | Yukako Ito | K. Takada | Nobuyuki Sugioka | H. Morita | K. Fukushima | N. Sugioka | Ayaka Ise | Ryo Hasegawa | Yukako Ito | Ryo Hasegawa | A. Ise
[1] Yukako Ito,et al. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin , 2010, Drug development and industrial pharmacy.
[2] Yukako Ito,et al. Self-dissolving micropile array chip as percutaneous delivery system of protein drug. , 2010, Biological & pharmaceutical bulletin.
[3] Yu-hui Wei,et al. Improving the dissolution and oral bioavailability of the poorly water‐soluble drug aloe‐emodin by solid dispersion with polyethylene glycol 6000 , 2009 .
[4] Noriyasu Kamei,et al. Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[5] A. Alpár,et al. Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain , 2009, Brain Research.
[6] Han‐Gon Choi,et al. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution , 2009, Archives of pharmacal research.
[7] M. Morishita,et al. Effect of cell-penetrating peptides on the nasal absorption of insulin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[8] Samir Mitragotri,et al. Micro-scale devices for transdermal drug delivery. , 2008, International journal of pharmaceutics.
[9] P. Gao,et al. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. , 2008, Molecular pharmaceutics.
[10] Petras Juzenas,et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[11] Yukako Ito,et al. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. , 2008, Biological & pharmaceutical bulletin.
[12] Yuqin Qiu,et al. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[13] Yukako Ito,et al. Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats. , 2008, Biological & pharmaceutical bulletin.
[14] K. Takada. Microfabrication-derived DDS: From batch to individual production. , 2008, Drug discoveries & therapeutics.
[15] Jung-Hwan Park,et al. Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.
[16] Yukako Ito,et al. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. , 2008, Chemical & pharmaceutical bulletin.
[17] Mark R Prausnitz,et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans , 2008, Proceedings of the National Academy of Sciences.
[18] Yukako Ito,et al. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. , 2008, International journal of pharmaceutics.
[19] Yukako Ito,et al. Percutaneous absorption of interferon-α by self-dissolving micropiles , 2008 .
[20] Shayne C. Gad,et al. Handbook of pharmaceutical biotechnology , 2007 .
[21] J. Bouwstra,et al. The Lipid Organization in Stratum Corneum and Model Systems Based on Ceramides , 2006 .
[22] B. W. Barry,et al. Enhancement in Drug Delivery , 2006 .
[23] Kanji Takada,et al. Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] K. Takada. Oral delivery of hematopoietic factors , 2006 .
[25] S. Kaehler,et al. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. , 2006, International journal of clinical pharmacology and therapeutics.
[26] C. Huck,et al. Characterisation of the thiol–disulphide chemistry of desmopressin by LC, μ-LC, LC-ESI-MS and Maldi-Tof , 2006, Amino Acids.
[27] J. Yoshimitsu,et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.
[28] A. M. Dyer,et al. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[30] M. Phillip,et al. Transdermal Delivery of Human Growth Hormone Through RF-Microchannels , 2005, Pharmaceutical Research.
[31] Li-Fang Wang,et al. Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix , 2005, Journal of biomaterials science. Polymer edition.
[32] M. Karlsson,et al. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. , 2004, British journal of clinical pharmacology.
[33] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[34] R. Neubert,et al. LC-MS determination of desmopressin acetate in human skin samples. , 2004, Journal of pharmaceutical and biomedical analysis.
[35] D. Barrow,et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery , 2004, The British journal of dermatology.
[36] G. Cevc. Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.
[37] Véronique Préat,et al. Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.
[38] Mark R Prausnitz,et al. Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.
[39] S. Mitragotri,et al. Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.
[40] N. Kollias,et al. Transdermal drug delivery with a pressure wave. , 2004, Advanced drug delivery reviews.
[41] Shuhei Yamada,et al. Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin‐binding neuroregulatory factors , 2004, FEBS letters.
[42] Regina Luttge,et al. Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .
[43] H. Eichler,et al. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations , 2003, European Journal of Clinical Pharmacology.
[44] Jong Hwa Song,et al. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. , 2003, International journal of pharmaceutics.
[45] T. Park,et al. Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release. , 2001, International journal of pharmaceutics.
[46] J L Cleland,et al. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.
[47] G. Schuler,et al. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. , 2001, The Journal of investigative dermatology.
[48] M. Wilson,et al. Chondroitin sulfate proteoglycan expression pattern in hippocampal development: Potential regulation of axon tract formation , 2000, The Journal of comparative neurology.
[49] Gerwin J. Puppels,et al. Automated depth-scanning confocal Raman microspectrometer for rapidin vivo determination of water concentration profiles in human skin , 2000 .
[50] M. Morishita,et al. Improving insulin enteral absorption using water-in-oil-in-water emulsion , 1998 .
[51] M. Morishita,et al. Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid. , 1998, Journal of pharmaceutical sciences.
[52] N. Utoguchi,et al. Nitric Oxide Donors Enhance Rectal Absorption of Macromolecules in Rabbits , 1998, Pharmaceutical Research.
[53] J. Grossiord,et al. Insulin in w/o/w multiple emulsions: biological activity after oral administration in normal and diabetic rats. , 1997, Journal of microencapsulation.
[54] T. Maruyama,et al. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. , 1996, Journal of pharmaceutical sciences.
[55] Y. Kawashima,et al. Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.
[56] M. Morishita,et al. Absorption of insulin using water-in-oil-in-water emulsion from an enteral loop in rats. , 1995, Biological & pharmaceutical bulletin.
[57] Akira Yamamoto,et al. Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats , 1994, Pharmaceutical Research.
[58] M. Schachner,et al. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties , 1994, The Journal of cell biology.
[59] M. Morishita,et al. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. , 1993, Biological & pharmaceutical bulletin.
[60] J E Riviere,et al. Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. , 1990, The Journal of investigative dermatology.
[61] K. Fukushima,et al. Phenylalanine derivatives enhancing intestinal absorption of insulin in mice. , 1988, Chemical & pharmaceutical bulletin.
[62] M. Ross,et al. Absorption enhancement of growth hormone from the gastrointestinal tract of rats , 1986 .
[63] Chandra Sekhar Kolli,et al. Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery , 2007, Pharmaceutical Research.
[64] Adrian C. Williams,et al. Penetration enhancers. , 2004, Advanced drug delivery reviews.
[65] F. Waldhauser,et al. Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children. , 1999, Clinical chemistry.
[66] A. Sintov,et al. Cross-linked chondroitin sulphate: characterization for drug delivery purposes. , 1995, Biomaterials.
[67] Kozo Takayama,et al. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats , 1992 .